Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computational combinatorial ligand design: application to human alpha-thrombin

A Caflisch1

  • 1Department of Biochemistry, University of Zürich, Switzerland.

Journal of Computer-Aided Molecular Design
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Silico Identification of JMJD3 Demethylase Inhibitors.

Journal of chemical information and modeling·2018
Same author

Iriomoteolides: novel chemical tools to study actin dynamics.

Chemical science·2018
Same author

Mechanism and Kinetics of Acetyl-Lysine Binding to Bromodomains.

Journal of chemical theory and computation·2015
Same author

Slow folding of cross-linked alpha-helical peptides due to steric hindrance.

The journal of physical chemistry. B·2010
Same author

CHARMM: the biomolecular simulation program.

Journal of computational chemistry·2009
Same author

Identification of the protein folding transition state from molecular dynamics trajectories.

The Journal of chemical physics·2009
Same journal

Repurposing bleomycin against Acinetobacter baumannii HisG: computational, biophysical, and antibacterial evidence.

Journal of computer-aided molecular design·2026
Same journal

Topological data analysis for antibody-drug conjugate payload discovery: a computational framework for mechanistic classification and target validation.

Journal of computer-aided molecular design·2026
Same journal

Commentary on the fundamentals and development of artificial intelligence models in the life sciences and best research practices.

Journal of computer-aided molecular design·2026
Same journal

RANQSAR: a standalone open-source application for reproducible machine learning-based QSAR analysis.

Journal of computer-aided molecular design·2026
Same journal

Integrating evolutionary and compositional features with ML and DL for robust and interpretable druggable protein prediction.

Journal of computer-aided molecular design·2026
Same journal

QUAD: a composite risk framework integrating uncertainty, applicability domain, and model disagreement for reliable QSAR predictions.

Journal of computer-aided molecular design·2026
See all related articles

A novel computational method uses fragment selection and combinatorial chemistry to design potential drug ligands. This approach efficiently identifies promising compounds by optimizing fragment placement and predicting binding affinity for macromolecular targets.

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Structural biology

Background:

  • Designing effective drug ligands requires understanding target molecule interactions.
  • Existing methods may lack efficiency in exploring diverse chemical spaces.

Purpose of the Study:

  • To present a new computational method for computer-aided ligand design.
  • To enable the combinatorial selection of fragments for favorable binding to macromolecular targets.

Main Methods:

  • Utilized multiple-copy simultaneous-search (MCSS) to find optimal fragment positions.
  • Calculated approximated binding free energy, including solvation effects (electrostatic and nonpolar).
  • Developed computational combinatorial ligand design (CCLD) program for automated compound generation and pruning.

Related Experiment Videos

Main Results:

  • MCSS identified favorable fragment interactions within the human alpha-thrombin active site.
  • CCLD generated diverse compounds, including those related to known high-affinity inhibitors.
  • The method suggested novel binding motifs for potential ligands.

Conclusions:

  • The MCSS-CCLD approach offers an efficient strategy for de novo ligand design.
  • This method has significant implications for accelerating drug discovery processes.
  • It successfully identifies known inhibitor patterns and proposes novel ligand candidates.